We anticipate Livanova can bring leverage down to the target range by 2027, which would put the firm's debt at levels typical of medtech firms. Interest coverage remains well within covenants, though, ...
Citi analyst Joanne Wuensch upgraded Medtronic (MDT) to Buy from Neutral with a price target of $107, up from $92. The stock initially fell 7% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback